MAIA Biotechnology Files 8-K
Ticker: MAIA · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1878313
Sentiment: neutral
Topics: 8-K, filing, regulatory
TL;DR
MAIA Bio filed an 8-K on 7/28/25 for 'Other Events' and financials. Details TBD.
AI Summary
MAIA Biotechnology, Inc. filed an 8-K on July 28, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only the reporting of their occurrence.
Why It Matters
This filing indicates that MAIA Biotechnology, Inc. has reported significant events or financial updates to the SEC, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: low — The filing is a standard procedural report without specific negative or positive disclosures, making the immediate risk level low.
Key Players & Entities
- MAIA Biotechnology, Inc. (company) — Registrant
- July 28, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of incorporation
- 001-41455 (commission_file_number) — SEC File Number
- 444 West Lake Street, Suite 1700 (address) — Principal executive offices
- Chicago, IL 60606 (address) — Principal executive offices
- (312) 416-8592 (phone_number) — Registrant's telephone number
FAQ
What specific 'Other Events' are being reported by MAIA Biotechnology, Inc. in this 8-K filing?
The filing does not specify the nature of the 'Other Events' beyond listing it as an item of disclosure.
What is the significance of the 'Financial Statements and Exhibits' being reported?
The filing indicates that financial statements and exhibits are being provided, but the specific content or nature of these documents is not detailed in the provided excerpt.
When was the earliest event reported in this 8-K filing?
The earliest event reported was on July 28, 2025.
Where is MAIA Biotechnology, Inc. incorporated?
MAIA Biotechnology, Inc. is incorporated in Delaware.
What is the principal executive office address for MAIA Biotechnology, Inc.?
The principal executive office is located at 444 West Lake Street, Suite 1700, Chicago, IL 60606.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding MAIA Biotechnology, Inc. (MAIA).